DK147812B - Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat - Google Patents
Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat Download PDFInfo
- Publication number
- DK147812B DK147812B DK195079AA DK195079A DK147812B DK 147812 B DK147812 B DK 147812B DK 195079A A DK195079A A DK 195079AA DK 195079 A DK195079 A DK 195079A DK 147812 B DK147812 B DK 147812B
- Authority
- DK
- Denmark
- Prior art keywords
- urokinase
- hsa
- lyophilized
- amino acid
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5682678A JPS54147916A (en) | 1978-05-12 | 1978-05-12 | Preparation of urokinase injection |
JP5682678 | 1978-05-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK195079A DK195079A (da) | 1979-11-13 |
DK147812B true DK147812B (da) | 1984-12-17 |
Family
ID=13038173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK195079AA DK147812B (da) | 1978-05-12 | 1979-05-10 | Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat |
Country Status (10)
Country | Link |
---|---|
US (1) | US4244943A (sv) |
JP (1) | JPS54147916A (sv) |
CA (1) | CA1115206A (sv) |
CH (1) | CH641046A5 (sv) |
DE (1) | DE2917899A1 (sv) |
DK (1) | DK147812B (sv) |
FR (1) | FR2425245A1 (sv) |
GB (1) | GB2021412B (sv) |
IT (1) | IT7949032A0 (sv) |
SE (1) | SE7904118L (sv) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5813521A (ja) * | 1981-07-16 | 1983-01-26 | Green Cross Corp:The | ミエロペルオキシダ−ゼの粉末製剤 |
US4350659A (en) * | 1981-07-30 | 1982-09-21 | Corning Glass Works | Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives |
JPS59139323A (ja) * | 1983-01-28 | 1984-08-10 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
SU1128601A1 (ru) * | 1983-05-10 | 1985-07-15 | Всесоюзный кардиологический научный центр АМН СССР | Урокиназа,иммобилизированна на фибриногене |
JPS6051119A (ja) * | 1983-08-30 | 1985-03-22 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
JPS61111684A (ja) * | 1984-11-05 | 1986-05-29 | Terumo Corp | 精製されたウロキナ−ゼ複合体の製造方法 |
JPS61124383A (ja) * | 1984-11-16 | 1986-06-12 | Unitika Ltd | 固定化線維素溶解活性酵素の安定化法 |
EP0208785B1 (en) * | 1985-01-14 | 1992-12-30 | Shiseido Company Limited | Fibrinophilic urokinase complex and process for its preparation |
JPS61238732A (ja) * | 1985-04-16 | 1986-10-24 | Green Cross Corp:The | ウロキナーゼ前駆体乾燥製剤 |
CA1336585C (en) * | 1985-04-16 | 1995-08-08 | Kazuo Morimoto | Method of stabilizing urokinase precursor and dry preparation containing said precursor |
NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
WO1990001334A1 (en) * | 1988-08-05 | 1990-02-22 | Codon | Formulations for plasminogen activator using aspartate |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
JPH02268681A (ja) * | 1989-04-07 | 1990-11-02 | Green Cross Corp:The | ウロキナーゼ前駆体の安定化方法及び乾燥製剤 |
AU635541B2 (en) * | 1989-05-17 | 1993-03-25 | Research Corporation Technologies, Inc. | Method and composition for the treatment of thrombosis in a mammal |
DE69012675T2 (de) * | 1989-06-30 | 1995-05-04 | Ucar Carbon Tech | Graphitfolie. |
EP2236617A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Methods of terminal sterilization of biofunctional compositions |
EP2563809B1 (en) * | 2010-04-27 | 2020-04-01 | Scil Technology GmbH | Stable aqueous mia/cd-rap formulations |
CN104906054B (zh) * | 2015-06-15 | 2017-08-25 | 武汉人福药业有限责任公司 | 一种尿激酶冻干剂的制备方法 |
CN111450052A (zh) * | 2020-04-22 | 2020-07-28 | 南京南大药业有限责任公司 | 一种尿激酶注射液制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE665076A (sv) * | 1963-12-23 | 1965-12-08 | ||
JPS5137343B2 (sv) * | 1972-12-07 | 1976-10-15 |
-
1978
- 1978-05-12 JP JP5682678A patent/JPS54147916A/ja active Pending
-
1979
- 1979-05-03 DE DE19792917899 patent/DE2917899A1/de not_active Withdrawn
- 1979-05-09 US US06/037,280 patent/US4244943A/en not_active Expired - Lifetime
- 1979-05-10 CH CH438379A patent/CH641046A5/de not_active IP Right Cessation
- 1979-05-10 DK DK195079AA patent/DK147812B/da not_active Application Discontinuation
- 1979-05-10 GB GB7916251A patent/GB2021412B/en not_active Expired
- 1979-05-10 SE SE7904118A patent/SE7904118L/sv not_active Application Discontinuation
- 1979-05-10 FR FR7911841A patent/FR2425245A1/fr active Granted
- 1979-05-11 CA CA327,420A patent/CA1115206A/en not_active Expired
- 1979-05-11 IT IT7949032A patent/IT7949032A0/it unknown
Also Published As
Publication number | Publication date |
---|---|
DE2917899A1 (de) | 1979-11-22 |
US4244943A (en) | 1981-01-13 |
CA1115206A (en) | 1981-12-29 |
FR2425245B1 (sv) | 1983-03-11 |
IT7949032A0 (it) | 1979-05-11 |
GB2021412A (en) | 1979-12-05 |
SE7904118L (sv) | 1979-11-13 |
DK195079A (da) | 1979-11-13 |
JPS54147916A (en) | 1979-11-19 |
CH641046A5 (de) | 1984-02-15 |
FR2425245A1 (fr) | 1979-12-07 |
GB2021412B (en) | 1982-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK147812B (da) | Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat | |
US5945098A (en) | Stable intravenously-administrable immune globulin preparation | |
US5130244A (en) | Stable aqueous thrombin solution | |
US7803911B2 (en) | Dried blood factor composition comprising trehalose | |
US7381796B2 (en) | Dried blood factor composition comprising trehalose | |
US4374763A (en) | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof | |
IL117405A (en) | Stable preparations of transglutaminase and processes for their preparation | |
WO1993001835A1 (en) | Stabilized human monoclonal antibody preparation | |
AU738413B2 (en) | Human growth hormone-containing aqueous pharmaceutical composition | |
JPS63165328A (ja) | 組織タンパクpp4含有医薬 | |
JPS6235756B2 (sv) | ||
KR950010321B1 (ko) | 인간 트롬빈 제제의 가열처리방법 | |
JP2002533473A (ja) | 微生物起源のヒアルロン酸分解酵素を含有する薬学的配合物 | |
US2978385A (en) | Stabilized chymotrypsin solution | |
US7244824B2 (en) | Dried blood factor composition comprising trehalose | |
JPS6059000A (ja) | インタ−フェロンの安定化方法 | |
JPH04198195A (ja) | Cpb―iの安定化方法及び製剤組成物 | |
JP2722143B2 (ja) | トリプシンインヒビター含有凍結乾燥製剤 | |
JP2971680B2 (ja) | 組織プラスミノーゲン活性化因子含有組成物 | |
SU1084024A1 (ru) | Состав дл стабилизации стрептокиназы | |
JP2861655B2 (ja) | ヒト尿性トリプシンインヒビター含有液状製剤及びその製造方法 | |
JPS59139323A (ja) | ウロキナ−ゼ乾燥製剤 | |
JP2717638B2 (ja) | 人血液凝固第ix因子含有製剤 | |
AU738891B2 (en) | Stable transglutaminase preparations and process for producing them | |
JPH04198196A (ja) | Cpb―iの安定化方法及びこの製剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PHB | Application deemed withdrawn due to non-payment or other reasons |